TR 291144

Drug Profile

TR 291144

Alternative Names: TR-290999; TR-291144; TRI-1144

Latest Information Update: 08 Nov 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Trimeris
  • Class Peptides
  • Mechanism of Action HIV fusion inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • Available For Licensing Yes

Highest Development Phases

  • No development reported HIV infections

Most Recent Events

  • 08 Nov 2010 TR 291144 is available for licensing as of 08 Aug 2008.
  • 16 Mar 2010 No development reported - Phase-I for HIV infections in USA (Parenteral)
  • 05 Aug 2009 Monogram Biosciences has been acquired by Laboratory Corporation of America Holdings
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top